| Name | Other Name | Use | Breast | Prostate | Lung | Colorectal | Pancreas | Ovarian | Esophagus | Liver | Lymphoma | Leukemia | Other |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AFP-L3 | Primary prevention | x | |||||||||||
| Alpha Catenin | Methylation marker | Prognosis | x | ||||||||||
| APC | Detection | x | |||||||||||
| BAT-26 | Microsatallite instability | Detection | x | ||||||||||
| Bladder cancer test | Diagnosis | x | |||||||||||
| BladderChek | NMP22 | Diagnosis | x | ||||||||||
| Breast Cancer Detection | Nipple Aspirate Fluid | Diagnosis | x | ||||||||||
| Breast Cancer Outcome Prediction Test | PIX2/TTF1 | Diagnosis | x | ||||||||||
| Cancer antigen 72-4 | CA 72-4 | Diagnosis | x | ||||||||||
| CDK family | Cyclin dependent kinase family | Management | x | ||||||||||
| CDKN24 | Methylation marker | Detection | x | ||||||||||
| CDP/Cux | Diagnosis | x | |||||||||||
| CellSearch | Circulating tumor cells | Diagnosis | x | ||||||||||
| CeMines CellCorrect Lab | Diagnosis | x | |||||||||||
| Chromosome 8q gain | Management | x | |||||||||||
| c-Kit pharmDx | Gleevec sensitivity test | Management | x | ||||||||||
| Colorectal cancer test | Diagnosis | x | |||||||||||
| Colorectal gene panel | 7 gene pharmacogenomic panel | Management | x | ||||||||||
| Colorectalert | Diagnosis | x | |||||||||||
| Conversion Analysis | Conversion Technology | Diagnosis | x | ||||||||||
| Cox-2 RNA | Stool | Detection | x | ||||||||||
| cPSA | Complexed PSA | Management | x | ||||||||||
| CupPrint | Management | x | |||||||||||
| Cyfra 21-1 | Cytokeratin fragment 19 | Diagnosis | x | ||||||||||
| Cytokeratin 20 | CK 20 | Diagnosis | x | ||||||||||
| CytoVision | Diagnosis | x | |||||||||||
| des-gamma carboxyprothrombin | Detection | x | |||||||||||
| DNA methylation | Oncomethylome | Detection | x | x | x | x | |||||||
| DNA methylation | Second Code | Diagnosis | x | x | x | ||||||||
| EEF1A2 | Elongation factor | Management | x | ||||||||||
| EGFR | Genzyme | Detection | x | x | x | ||||||||
| EGFR | Management | x | |||||||||||
| EPCA | Diagnosis | x | |||||||||||
| eTag | Management | x | x | ||||||||||
| Genomic Test | 3q, 7q, 16q, 17pter-q21 | Diagnosis | x | ||||||||||
| GOS | Stool | Detection | x | ||||||||||
| GSTM1 | Prediction | x | |||||||||||
| GSTP1 | Management | x | |||||||||||
| Her-1, Her-2, Her-3, Her-4 | Diagnosis | x | |||||||||||
| HLA-E | Prognosis | x | |||||||||||
| HP1alpha | Management | x | |||||||||||
| HPV test | DNA with Pap Test | Diagnosis | x | ||||||||||
| HPV test | Human papilloma virus cell swab | Diagnosis | x | ||||||||||
| IGF-II | Prediction | x | |||||||||||
| IMI breast cancer test | Diagnosis | x | |||||||||||
| Immunocyt/ uCyt | Diagnosis | x | |||||||||||
| Iressa test | Management | x | |||||||||||
| Key2 | Diagnosis | x | |||||||||||
| K-ras | Detection | x | x | ||||||||||
| Leukemia Affymetrix Chip | Diagnosis | x | |||||||||||
| Leukemia blood test | MRD test | Recurrence | x | ||||||||||
| Lung cancer test | Diagnosis | x | |||||||||||
| Lung cancer test | Electronic Nose | Diagnosis | x | ||||||||||
| LungAlert | Diagnosis | x | |||||||||||
| Lysophopholipids | LPA | Detection | x | ||||||||||
| M2-PK | Primary prevention | x | |||||||||||
| MammaPrint | Management | x | |||||||||||
| Matrix metalloproeinases | MMP | Detection | x | ||||||||||
| Melanoma inhibiting antigen | MIA | Diagnosis | x | ||||||||||
| Melastatin | mRNA expression | Management | x | ||||||||||
| MESOMARK | Diagnosis | x | |||||||||||
| MGMT | Methylation marker | Detection | x | ||||||||||
| Microsatelitte Analysis | Urine MicroSatellite Analysis | Detection | x | ||||||||||
| MLH1 | Methylation marker | Detection | x | ||||||||||
| MN protein | Detection | x | |||||||||||
| MSA | Management | x | |||||||||||
| MSA analysis | Microsatellite DNA | Diagnosis | x | ||||||||||
| NAF test | Diagnosis | x | |||||||||||
| NMP179 | Diagnosis | x | |||||||||||
| NMP22 | Matritek's Bladderchek test | Detection | x | ||||||||||
| NMP35 | Diagnosis | x | |||||||||||
| NMP48 | Diagnosis | x | |||||||||||
| NMP66 | Diagnosis | x | |||||||||||
| OncoVue breast cancer risk test | Tagit | Primary prevention | x | ||||||||||
| Ovacheck | Diagnosis | x | |||||||||||
| Ovarian cancer biomarker test | Diagnosis | x | |||||||||||
| Ovarian cancer test | Diagnosis | x | |||||||||||
| Ovarian cancer test | Ovarian Cancer Prognostic Profile | Management | x | ||||||||||
| Ovarian pap test | Detection | x | |||||||||||
| p16, p15, p14 deletions | Management | x | x | ||||||||||
| p202 | Management | x | |||||||||||
| p53 Affymetrix Chip | Diagnosis | x | |||||||||||
| Prostate 63 | AsymmetRx | Management | x | ||||||||||
| Prostate biomarkers | Management | x | |||||||||||
| Prostate Cancer Blood Test | ProteomeDx | Diagnosis | x | ||||||||||
| Protein Profile test | Lysophosphatidic acid (LPA) | Recurrence | x | ||||||||||
| PSA testing | In office | Diagnosis | x | ||||||||||
| PSMA | Prostate specific membrane antigen | Management | x | ||||||||||
| PSP94 | Prostate secratory protein | Diagnosis | x | ||||||||||
| PTEN tumor suppressor | Management | x | |||||||||||
| PyloriProbe | DR70 | Diagnosis | x | ||||||||||
| Recaf | Alpha feto protein receptor | Diagnosis | x | x | x | x | |||||||
| RhoC GTPase | Management | x | |||||||||||
| S100 | Diagnosis | x | |||||||||||
| SELDI-TOF-MS | Molecular profiling using SELDI | Management | x | x | x | x | |||||||
| SurePath | Diagnosis | x | |||||||||||
| Telomerase | hTR, HTerRT | Diagnosis | x | ||||||||||
| TGF genes | Prognosis | x | |||||||||||
| TUO test | Diagnosis | x | |||||||||||
| uPM3 | PCA3 assay | Diagnosis | x | ||||||||||
| Urinary plasminogen activator | suPAR | Detection | x | ||||||||||
| Urine test for cervical cancer | Diagnosis | x | |||||||||||
| VEGF | Management | x | |||||||||||
| WISP3 | Management | x |